Please login to the form below
Anokion
This page shows the latest Anokion news and features for those working in and with pharma, biotech and healthcare.
Celgene pays $300m upfront for immunology start-up Delinia
The Delinia acquisition comes in the wake of other bolt-on deals most recently its takeover earlier this month of another immunology specialist - Anokion - and its December purchase of oncology, neurodegeneration
Latest news
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
Latest Intelligence
-
Pharma deals in June 2015
form a new company, Kanyos Bio, to exploit Anokion's technology for the development of therapeutics for certain autoimmune indications. ... Collaboration. 1, 000. Anokion/ Astellas Pharma. Formation of Kanyos Bio based on Anokion's technology for
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Featured jobs
- Entry Level Editorial Assistant – Medical Education –Buckinghams...
-
Highly Competitive
-
Account Director
-
Salary TBC
- Account Director, Healthcare Communications Agency
-
£54, 000- £60, 000
-
Account Executive
-
Salary TBC
- Scientific Director - Medical Communications - Berkshire
-
Excellent package on offer
-
Senior Medical Writer
-
Salary TBC
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
-
Account Supervisor
-
Salary TBC
- Senior Editor - Medical Communications - South East - Buckingham...
-
Highly competitive salary &package
-
Account Director, Medical Education
-
Salary TBC
Subscribe to our email news alerts
- Genital herpes vaccine candidate heads for human studies
- Roche’s Spinraza, Zolgensma rival risdiplam hits the mark in SMA
- FDA advisors say no to empagliflozin in type 1 diabetes
- Novartis makes case for NASH candidate tropifexor
- MSD hangs ‘for sale’ sign on French facility, shedding 207 staff
- AbbVie sells $30bn of bonds ahead of Allergan merger
- What do Healthcare Professionals think about the inclusion of remote selling techniques?
- Takeda highlights 12 NMEs with $10bn-plus sales potential at R&D day
- BeiGene bags FDA approval for first product Brukinsa in lymphoma
- Amarin wins FDA advisory nod for Vascepa cardiovascular expansion
- Shionogi scores FDA approval for new cUTI antibiotic
- Merck acquires pre-clinical biotech Calporta for up to $576m
PMHub
Hayward Medical Communications
Hayward Medical Communications has been supporting partners in every sector of the healthcare industry to deliver evidence-based, clinically relevant and...
Latest intelligence
- What do Healthcare Professionals think about the inclusion of remote selling techniques?
- Evolving to a digitally focused pharma / healthcare company - an organisational roadmap...
- Strengthening business competition and reducing anti-competitive practices
- How the CMA is tackling high prices for essential drugs...
- Pharmaceutical innovation in the APAC region
- A first-of-its-kind study paints a vivid picture of the APAC region’s future...
Quick links
Infographics
